A.R.T. Advisors, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2018$1,132,000
-56.3%
29,813
-48.0%
0.05%
-50.5%
Q2 2018$2,590,000
+48.1%
57,313
+58.3%
0.10%
+50.0%
Q1 2018$1,749,000
+405.5%
36,213
+310.9%
0.07%
+366.7%
Q4 2017$346,000
-87.7%
8,813
-90.3%
0.02%
-89.6%
Q3 2017$2,819,000
+3.3%
90,813
-9.0%
0.14%
-0.7%
Q2 2017$2,729,000
+362.5%
99,813
+523.3%
0.14%
+437.0%
Q1 2017$590,000
-43.7%
16,013
-74.7%
0.03%
-48.1%
Q2 2016$1,048,000
+17.2%
63,180
+12.0%
0.05%
+30.0%
Q1 2016$894,000
+87.0%
56,400
+281.1%
0.04%
+73.9%
Q4 2015$478,00014,8000.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders